Robert Wynn, MD, MRCP, FRCPath

Royal Manchester Children's Hospital, United Kingdom

Disclosure(s): AVRO BIO: Grant/Research Support, Milestone payments MPSII clinical trial; Orchard Therapeutics: Grant/Research Support, Milestone payments MPSII clinical trial

Poster(s):

• (P-103) Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT